Literature DB >> 3469661

Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice.

H Farza, A M Salmon, M Hadchouel, J L Moreau, C Babinet, P Tiollais, C Pourcel.   

Abstract

We have investigated the basis for liver-specific and sex-linked expression of hepatitis B surface antigen (HBsAg) gene in transgenic mice by monitoring the level of liver HBsAg mRNA and serum HBsAg at different stages of development and in response to sex-hormone regulation. Transcription of the HBsAg gene starts at day 15 of development, together with that of the albumin gene, and reaches a comparable level at birth. HBsAg mRNA level and HBsAg production are parallel in males and females during prenatal development and until the first month of life, but HBsAg gene expression increases 5-10 times in males at puberty. After castration, the level of expression decreases dramatically in both males and females and is subsequently increased by injection of testosterone or estradiol. Glucocorticoids also regulated positively expression of the HBsAg gene. Our results suggest that sex hormones play a role in hepatitis B virus gene expression during natural infection and could explain the difference in incidence of chronic carriers between men and women.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3469661      PMCID: PMC304391          DOI: 10.1073/pnas.84.5.1187

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

Review 2.  Sexual dimorphism in the liver.

Authors:  A K Roy; B Chatterjee
Journal:  Annu Rev Physiol       Date:  1983       Impact factor: 19.318

3.  Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone.

Authors:  N Huh; T Utakoji
Journal:  Gan       Date:  1981-02

4.  Transcriptional regulation of mouse liver metallothionein-I gene by glucocorticoids.

Authors:  L J Hager; R D Palmiter
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

5.  Estrogen regulation of the avian transferrin gene in transgenic mice.

Authors:  R E Hammer; R L Idzerda; R L Brinster; G S McKnight
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

6.  Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA.

Authors:  C Pourcel; A Louise; M Gervais; N Chenciner; M F Dubois; P Tiollais
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

7.  Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice.

Authors:  C Babinet; H Farza; D Morello; M Hadchouel; C Pourcel
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

8.  Transcriptional regulation of the tryptophan oxygenase gene in rat liver by glucocorticoids.

Authors:  U Danesch; S Hashimoto; R Renkawitz; G Schütz
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

Review 9.  The hepatitis B virus.

Authors:  P Tiollais; C Pourcel; A Dejean
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

10.  Glucocorticoid regulation of mouse mammary tumor virus sequences in transgenic mice.

Authors:  S R Ross; D Solter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

View more
  29 in total

1.  DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state.

Authors:  M Mancini; M Hadchouel; H L Davis; R G Whalen; P Tiollais; M L Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication.

Authors:  U Klöcker; U Schultz; H Schaller; U Protzer
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 3.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors:  Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  A dominant modifier of transgene methylation is mapped by QTL analysis to mouse chromosome 13.

Authors:  P Valenza-Schaerly; B Pickard; J Walter; M Jung; L Pourcel; W Reik; D Gauguier; G Vergnaud; C Pourcel
Journal:  Genome Res       Date:  2001-03       Impact factor: 9.043

Review 5.  Hepatic disorders in chronic kidney disease.

Authors:  Fabrizio Fabrizi; Piergiorgio Messa; Carlo Basile; Paul Martin
Journal:  Nat Rev Nephrol       Date:  2010-04-13       Impact factor: 28.314

6.  Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus.

Authors:  Robert Yung-Liang Wang; Chia-Ning Shen; Min-Hui Lin; David Tosh; Chiaho Shih
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.

Authors:  E Malanchère-Brès; P J Payette; M Mancini; P Tiollais; H L Davis; M L Michel
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice.

Authors:  P N Gilles; G Fey; F V Chisari
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice.

Authors:  Phillip Moheno; John Morrey; Dietmar Fuchs
Journal:  J Transl Med       Date:  2010-03-31       Impact factor: 5.531

10.  Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity.

Authors:  C Pourcel; P Tiollais; H Farza
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.